or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    C 132.19 2.43% 3.13
    MRNA closed up 0.58 percent on Wednesday, May 15, 2024, on 80 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    70 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Slingshot Bullish Bullish Swing Setup 2.43%
    Stochastic Reached Overbought Strength 2.43%
    Wide Bands Range Expansion 2.43%
    Overbought Stochastic Strength 2.43%
    Up 3 Days in a Row Strength 2.43%
    Wide Bands Range Expansion 3.02%
    180 Bullish Setup Bullish Swing Setup 5.19%
    Multiple of Ten Bullish Other 5.19%
    Gapped Up Strength 5.19%
    Multiple of Ten Bearish Other 12.68%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 2 hours ago
    60 Minute Opening Range Breakout about 3 hours ago
    Up 1% about 3 hours ago
    Slingshot Bullish Entry about 4 hours ago
    Rose Above Previous Day's High about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MRNA Chart by TradingView
    Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    May 15 Moderna Q1: A Promising Pipeline Is Undervalued
    May 14 Evercore says biotech ‘winter is finally thawing’
    May 14 Is This a Setback for Moderna?
    May 13 As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave
    May 13 Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
    May 13 While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
    May 13 Company News For May 13, 2024
    May 13 Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
    May 13 Bull Market and Beyond: 2 Stocks Just Waiting to Soar
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 142.79
    52 Week Low 62.65
    Average Volume 3,691,681
    200-Day Moving Average 98.53
    50-Day Moving Average 109.35
    20-Day Moving Average 115.54
    10-Day Moving Average 123.87
    Average True Range 5.46
    RSI (14) 68.45
    ADX 26.9
    +DI 29.24
    -DI 16.21
    Chandelier Exit (Long, 3 ATRs) 113.56
    Chandelier Exit (Short, 3 ATRs) 115.68
    Upper Bollinger Bands 133.55
    Lower Bollinger Band 97.54
    Percent B (%b) 0.88
    BandWidth 31.17
    MACD Line 5.64
    MACD Signal Line 4.56
    MACD Histogram 1.0799
    Fundamentals Value
    Market Cap 49.21 Billion
    Num Shares 381 Million
    EPS -9.23
    Price-to-Earnings (P/E) Ratio -13.98
    Price-to-Sales 3.91
    Price-to-Book 2.48
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 135.35
    Resistance 3 (R3) 134.68 131.93 134.30
    Resistance 2 (R2) 131.93 130.33 132.26 133.95
    Resistance 1 (R1) 130.49 129.34 131.21 131.16 133.60
    Pivot Point 127.74 127.74 128.10 128.07 127.74
    Support 1 (S1) 126.30 126.14 127.02 126.97 124.52
    Support 2 (S2) 123.55 125.15 123.88 124.17
    Support 3 (S3) 122.11 123.55 123.82
    Support 4 (S4) 122.78